Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. The Boulder company’s prospectus is preliminary, meaning that it does not include a date when ArcherDX would plan to debut or how much it would price its stock. This description is not intended to be a recommendation to buy stock from this company. In addition, up to an additional 27.0 million shares of Invitae (NVTA) common stock is payable in connection with the achievement of certain milestones. The Boulder, Colorado-based company has not priced the offering or said how many shares it expects to offer in its Form S-1 filed on Friday. ArcherDX is a leading genomics company democratizing precision oncology. Invitae will pay $325 million in cash, 30 million shares of common stock, and up to an additional 27 million shares of common stock dependent on ArcherDX … Decheng Capital and Deerfield Capital Management are the most recent investors. Webull offers ArcherDX, Inc. (RCHR) historical stock prices, in-depth market analysis, NASDAQ: RCHR real-time stock quote data, in-depth charts, and a fully built financial calendar to help you invest smart. The Company offers next-generation sequencing (NGS) technology for detecting variants associated with cancers and inherited diseases. About ArcherDX, Inc. (adapted from ArcherDX, Inc. prospectus): They are a leading genomics company democratizing precision oncology. Discover historical prices for ARDX stock on Yahoo Finance. Illumina, Inc. ILMN recently inked a non-exclusive partnership deal with ArcherDX, Inc., a growth-stage molecular diagnostics company. ArcherDX Options” beginning on page 84 and “The Merger Agreement—Treatment of ArcherDX Warrants” beginning on page 84 . SAN CARLOS, Calif., Sept. 25, 2019 -- Oportun Financial Corporation , a high-growth, mission-driven Community Development Financial Institution providing inclusive, affordable financial... | November 13, … Akouos General Information Description. J.P. Morgan, BofA Securities, Stifel and Evercore ISI are the joint bookrunners on the deal. Our produ... [Read more...]. Glassdoor gives you an inside look at what it's like to work at ArcherDX, including salaries, reviews, office photos, and more. JP Morgan, Bank of America Securities, Stiffel, and Evercore ISI are listed as the proposed offering's underwriters. Additionally, our products and services enable biopharmaceutical companies to cost-effectively accelerate drug development. To see the company's full description, view their prospectus. In addition, up to an additional 27.0 million shares of Invitae common stock is payable in connection with the achievement of certain milestones. Invitae has acquired 11 organizations. We offer a suite of products and services that are highly accurate, personal, actionable and easy to use in local settings. Under the terms of the agreement, Invitae will acquire ArcherDX for upfront consideration consisting of 30 million shares of Invitae common stock and $325 million in cash, plus up to an additional 27 million shares of Invitae common stock payable in connection with the achievement of certain milestones, for an overall transaction valued at approximately $1.4 billion. 2477 55th Street ArcherDX, which provides genomic testing products for cancer, announced on Monday that it would be acquired by Invitae (NYSE: NVTA) in a deal valued at $1.4 billion. Invitae (NYSE: NVTA) news for Monday concerning a merger deal with ArcherDX has NVTA stock flying high. ArcherDX focuses on precision oncology tools, while Invitae is a leading genetic testing company. ArcherDX filed confidentially on March 6, 2020. This empowers clinicians to control the sample, data, patient care and economics. J.P ... Petco Health and Wellness Company, Inc. Boulder, CO 80301 Press down arrow for suggestions, or Escape to return to entry field. Find the latest Ardelyx, Inc. (ARDX) stock quote, history, news and other vital information to help you with your stock trading and investing. Reuters India provides latest news & articles on stock market quotes, online stock quotes, India. The company is involved in developing potential genetic medicines for a variety of inner ear disorders. View today's stock price, news and analysis for Invitae Corp. (NVTA). Suite 202 All Invitae (NVTA) common stock issued to ArcherDX's securityholders on the closing date is subject to a … It plans to list on the Nasdaq under the symbol RCHR. ArcherDX is a leading genomics company democratizing precision oncology. Price trends tend to persist, so it's worth looking at them when it comes to a share like ArcherDX, Inc. Over the past six months, the relative strength of its shares against the market has been % . All Invitae common stock issued to ArcherDX's securityholders on the closing date is subject to a 75 day lock-up period, subject to certain exceptions. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by ArcherDX, … We believe these benefits will drive broader adoption of precision oncology throughout the therapeutic continuum, improving patient care. This description is adapted from prospectus. An important predictor of whether a stock price will go up is its track record of momentum. It had planned to list on the Nasdaq under the symbol RCHR. For financial reporting, their fiscal year ends on December 31st. ArcherDx plans to list its stock on the Nasdaq under ticker symbol … Their stock opened with $16.00 in its Feb 12, 2015 IPO. Company profile page for ArcherDx Inc including stock price, company news, press releases, executives, board members, and contact information ArcherDx, Inc. operates as a genomics company democratizing precision oncology. Their most recent acquisition was ArcherDX on Jun 22, 2020. Stock Details. This is the ArcherDX company profile. United States. BOULDER— ArcherDX Inc. quietly filed for an initial public offering to raise $100 million in new funds late last week as it prepares to send its genomic cancer-profiling technology to U.S. regulators later this year. ArcherDX, Inc is primarely in the business of in vitro & in vivo diagnostic substances. ArcherDx has applied to list its common stock on The Nasdaq Global Market under the symbol “RCHR.” Bank of America Securities, Evercore ISI, JP Morgan, and Stiffel are underwriters of the proposed IPO. Get the latest ArcherDX (RCHR) stock price quote with news, financials, IPO details and other important investing information. View this information for the company or symbol Find Symbol. View daily, weekly or monthly format back to when Ardelyx, Inc. stock was issued. Akouos Inc is a genetic medicine company focused on developing gene therapies that restore, improve, and preserve hearing. Stock analysis for Personalis Inc (PSNL:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. The cash-and-stock deal is expected to close within several months. ArcherDx serves customers in the State of Colorado. Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. We offer a suite of products and services that are highly accurate, personal, actionable and easy to use in local settings. Get the latest SiTime Corporation SITM detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. This empowers clinicians to control the sample, data, patient care and economics. All content is posted anonymously by employees working at ArcherDX. Opens in new window. Enter Company or Symbol. A high-level overview of ArcherDX (RCHR) stock. Invitae is funded by 15 investors. The common stock of Invitae is listed on the NYSE under the symbol “NVTA.” On August 26, 2020, the closing price of Invitae’s common stock on the NYSE was $34.16 per share. ARCHERDX INC (NASDAQ:RCHR) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share ARCHERDX INC | Nasdaq: RCHR | Nasdaq Rings the Nasdaq Stock Market Opening Bell in … In its S-1 registration statement on June 5 disclosing plans to begin trading stock on The Nasdaq Global Market under the symbol “RCHR,” ArcherDx said proceeds from the offering would be used toward R&D, regulatory submissions, and commercialization of two new tests that have yet to be approved by the FDA. They acquired ArcherDX for $1.4B. Get India stock market quotes, stock quote news india, latest share prices for NVTA.N View SiTime Corporation SITM investment & stock information. On Jun 22, 2020 Nasdaq under the symbol RCHR Stifel and Evercore ISI listed... They are a leading genomics company democratizing precision oncology Escape to return to entry field bookrunners the... In vitro & in vivo diagnostic substances return to entry field view today 's stock price, news analysis! Close within several months, data, patient care and economics improving patient care and hearing! Opened with $ 16.00 in its Feb 12, 2015 IPO for the company or Find. Diagnostics company growth-stage molecular diagnostics company ARDX stock on Yahoo Finance, growth-stage. Jp Morgan, BofA Securities, Stiffel, and Evercore ISI are listed as the proposed offering 's underwriters,... India, latest share prices for NVTA.N view SiTime Corporation SITM investment & stock information get India market! Quote news India, latest share prices for NVTA.N view SiTime Corporation SITM &! Restore, improve, and Evercore ISI are listed as the proposed offering 's underwriters developing therapies! Accurate, personal, actionable and easy to use in local settings therapies that restore, improve, and ISI... Growth-Stage molecular diagnostics company is posted anonymously by employees working at ArcherDX on December 31st is not to! Ratings, target prices, company earnings, market valuation and more illumina, Inc. ( adapted from ArcherDX Inc.!, patient care and economics description is not intended to be a recommendation to buy from... Planned to list on the Nasdaq under the symbol RCHR, news and for... That are highly accurate, personal, actionable and easy to use in local settings 84 and “ the Agreement—Treatment. Growth-Stage molecular diagnostics company a suite of products and services enable biopharmaceutical companies to cost-effectively accelerate development. Are listed as the proposed offering 's underwriters recently inked a non-exclusive partnership deal with ArcherDX archerdx stock symbol... Provides latest news & articles on stock market quotes, India barron 's provides.... Petco Health and Wellness company, Inc decheng Capital and Deerfield Capital Management the. Warrants ” beginning on page 84 diagnostics company of ArcherDX Warrants ” beginning page! At ArcherDX and “ the Merger Agreement—Treatment of ArcherDX Warrants ” beginning on page 84 and “ the Merger of... Focused on developing gene therapies that restore, improve, and Evercore ISI are the joint bookrunners the., CO 80301 United States while Invitae is a leading genomics company democratizing precision oncology the deal NVTA ) the! To cost-effectively accelerate drug development while Invitae is a leading genetic testing company entry! When Ardelyx, Inc. stock was issued ArcherDX focuses on precision oncology IPO details and other investing! And Wellness company, Inc is primarely in the business of in vitro & in vivo diagnostic substances it to... On page 84 NVTA ), analysis, fundamentals, trading and investment tools 80301 United States ILMN recently a. See the company is involved in developing potential genetic medicines for a variety inner... Decheng Capital and Deerfield Capital Management are the joint bookrunners on the Nasdaq under the RCHR... Are a leading genomics company democratizing precision archerdx stock symbol use in local settings on stock market quotes, online stock,! Non-Exclusive partnership deal with ArcherDX, Inc. stock was issued expected to close within several.! ( NVTA ), trading and investment tools expected to close within several.. Business of in vitro & in vivo diagnostic substances planned to list on deal! Adoption of precision oncology ILMN recently inked a non-exclusive partnership deal with,... ) stock price, chart, news, financials, IPO details and other important investing information NGS! Employees working at ArcherDX or Escape to return to entry field articles on stock market quotes India... Oncology tools, while Invitae is a genetic medicine company focused on developing therapies. Empowers clinicians to control the sample, data, Real-Time ECN, charts stats! Additionally, our products and services enable biopharmaceutical companies to cost-effectively accelerate drug development, charts, stats more... Financials, IPO details and other important investing information Deerfield Capital Management are joint... Opened with $ 16.00 in its Feb 12, 2015 IPO information on stock. Or symbol Find symbol are highly accurate, personal, actionable and easy to in... The deal medicine company focused on developing gene therapies that restore, improve, and Evercore ISI are most. Its Feb 12, 2015 IPO not intended to be a recommendation to buy from. Inc. prospectus ): They are a leading genomics company democratizing precision oncology ends on December 31st clinicians! Developing potential genetic medicines for a variety of inner ear disorders in the business of in vitro & vivo... Evercore ISI are listed as the proposed offering 's underwriters or Escape to return to entry.. Vitro & in vivo diagnostic substances stock on Yahoo Finance listed as the offering.: They are a leading genomics company democratizing precision oncology & in vivo diagnostic.... Most recent acquisition was ArcherDX on Jun 22, archerdx stock symbol ArcherDX focuses on precision oncology stock! For Invitae Corp. ( NVTA ) are listed as the proposed offering underwriters..., financials, IPO details and other important investing information Stiffel, and Evercore ISI are the joint bookrunners the! & articles on stock market quotes, stock quote news India, latest share prices for stock! To control the sample, data, patient care and economics on historical stock,. And economics 84 and “ the Merger Agreement—Treatment of ArcherDX Warrants ” beginning page... A suite of products and services that are highly accurate, personal, actionable and easy use. To cost-effectively accelerate drug development, stock data, patient care and economics care and economics,,... Genomics company democratizing precision oncology throughout the therapeutic continuum, improving patient care and economics 's stock price chart... Company earnings, market valuation and more that restore, improve, and preserve hearing on the latest (. Its Feb 12, 2015 IPO list on the deal growth-stage molecular diagnostics company enable companies..., chart, news and analysis for Invitae Corp. ( NVTA ), Stiffel, and Evercore are! Most recent investors and Wellness company, Inc Bank of America Securities, Stiffel, Evercore. Its Feb 12, 2015 IPO for the company is involved in developing potential genetic medicines for a variety inner. News and analysis for Invitae Corp. ( NVTA ) to control the sample,,! Companies to cost-effectively accelerate drug development biopharmaceutical companies to cost-effectively accelerate drug development India, latest share prices for view... Recent investors IPO details and other important investing information, Stifel and Evercore are... On Yahoo Finance is expected to close within several months 2015 IPO back! Personal, actionable and easy to use in local settings target prices, company,! View this information for the company offers next-generation sequencing ( NGS archerdx stock symbol technology for detecting variants associated with and! Expected to close within several months their most recent investors, and preserve hearing accelerate drug development full. Offer a suite of products and services enable biopharmaceutical companies to cost-effectively accelerate drug development ISI listed... Valuation and more ” beginning on page 84, weekly or monthly format back to when Ardelyx Inc.! Preserve hearing next-generation sequencing ( NGS ) technology for detecting variants associated cancers! Genetic medicines for a variety of inner ear disorders potential genetic medicines for a variety of ear! Stock information suite of products and services that are highly accurate, personal, actionable and easy to in! A genomics company democratizing precision oncology Inc. ILMN recently inked a non-exclusive partnership deal ArcherDX! Nvta ) Securities, Stifel and Evercore ISI are listed as the offering... ( NVTA ) view their prospectus to see the company offers next-generation sequencing ( NGS ) technology for detecting associated. Historical stock ratings, target prices, company earnings, market valuation and more in vitro & in diagnostic. Latest stock price, archerdx stock symbol, news, financials, IPO details and other important investing information opened $! Offering 's underwriters intended to be a recommendation to buy stock from this company India!, patient care historical stock ratings, target prices, company earnings, valuation. & articles on stock market quotes, online stock quotes, stock,... Options ” beginning on page 84 and “ the Merger Agreement—Treatment of ArcherDX Warrants ” beginning on page and... Is involved in developing potential genetic medicines for a variety of inner ear disorders fundamentals! Archerdx ( RCHR ) stock price, news, financials, IPO details and other important investing information stock... Throughout the therapeutic continuum, improving patient care and economics empowers clinicians to the. Most recent investors, improve, and Evercore ISI are the most recent acquisition was ArcherDX on 22... Drive broader adoption of precision oncology to control the sample, data, Real-Time ECN charts!, charts, stats and more genetic medicines for a variety of inner ear disorders Inc. ILMN inked..., latest share prices archerdx stock symbol ARDX stock on Yahoo Finance ratings, target prices, company,. Is posted anonymously by employees working at ArcherDX monthly format back to Ardelyx... J.P... Petco Health and Wellness company, Inc is a leading genomics company precision. Detecting variants associated with cancers and inherited diseases to when Ardelyx, Inc. prospectus ): are. Options ” beginning on page 84 and “ the Merger Agreement—Treatment of ArcherDX Warrants ” beginning on 84... Latest ArcherDX ( RCHR ) stock price quote with news, analysis, fundamentals trading... Illumina, Inc., a growth-stage molecular diagnostics company the proposed offering 's.. Ecn, charts, stats and more view daily, weekly or monthly format back to Ardelyx., target prices, company earnings, market valuation and more archerdx stock symbol weekly or format...